New York · 2025 Regular Session · Bill
A 10327: Requires the health equity council to issue mandates related to the treatment of sickle cell disease
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
A 10327 is a bill introduced in the New York House on February 20, 2026. According to its official title, it concerns: Requires the health equity council to issue mandates related to the treatment of sickle cell disease. Primary sponsor: Alicia Hyndman (Democratic). Most recent recorded action (February 20, 2026): REFERRED TO HEALTH.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.
Requires the health equity council to issue mandates related to the treatment of sickle cell disease; requires the commissioner of health to adhere to and act upon the recommendations and mandates of the health equity council.
Sponsors
Sponsors by party (alphabetical): Democratic 1
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Alicia Hyndman | Primary sponsor | Democratic | House | 29 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- REFERRED TO HEALTH